Part B Insider (Multispecialty) Coding Alert

Published on Wed Sep 28, 2011 PDF

Keep a careful eye on your vaccination reimbursement this month.

Part B practices will benefit from three new tests that you'll be able to report as "CLIA-waived," thanks to an Oct. 21 CMS transmittal on the matter. According to MLN Matters article 2321, CMS will now consider these tests CLIA-waived.

You'll have to append Modifier QW (CLIA-waived test) to these codes, which include the following, among others:

• 81003--Germaine Laboratories Inc. AimStrip Urine Analyzer and Mediwatch urinewatch Urine Analyzer
• G0434--UCP Biosciences, Inc. Drug Screening Test Cups, Diagnostic Test Group Clarity Multiple Drug Screen Cups, and Jant Pharmacal Accutest Drug of Abuse Urine Cup Test

To read the complete article, which has an implementation date of Jan. 3, 2012, visit https://www.cms.gov/transmittals/downloads/R2321CP.pdf.